Chargement en cours...

FGL2 as a Multimodality Regulator of Tumor-Mediated Immune Suppression and Therapeutic Target in Gliomas

BACKGROUND: Fibrinogen-like protein 2 (FGL2) may promote glioblastoma multiforme (GBM) cancer development by inducing multiple immune-suppression mechanisms. METHODS: The biological significance of FGL2 expression was assessed using the The Cancer Genome Atlast (TCGA) glioma database and tumor lysat...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Natl Cancer Inst
Auteurs principaux: Yan, Jun, Kong, Ling-Yuan, Hu, Jiemiao, Gabrusiewicz, Konrad, Dibra, Denada, Xia, Xueqing, Heimberger, Amy B., Li, Shulin
Format: Artigo
Langue:Inglês
Publié: Oxford University Press 2015
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4554195/
https://ncbi.nlm.nih.gov/pubmed/25971300
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djv137
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!